trial

Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy

NCTId NCT06529029
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2, Phase 3 · Recruiting
Enrollment 30 (estimated)
Sponsored by Michigan State University
Primary completion 2026-07-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2, Phase 3
Status
Recruiting
Enrollment
30 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2024-07-03
Primary completion
2026-07-01
Eligibility
ALL · 18 Years · 90 Years

Interventions & indications

Drugs
Sigma-Stim

Sponsors

Michigan State UniversityLead Sponsor
Pine Rest Christian Mental Health ServicesCollaborator

Investigators

1
Nagy A Youssef, MD, PhDPrincipal Investigator

Sites

1 total
Grand Rapids, United States

Linked catalysts

1
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral — primary completion2026-07-01

Facts & assertions

4 sourced
Enrollment
30
Phase
PHASE2,PHASE3
Primary Completion Date
2026-07-01
Status
RECRUITING
relationships
The graph out of here
drug
Sigma-Stim
drug
lead_sponsor
Michigan State University
company
collaborator
Pine Rest Christian Mental Health Services
company
indication
Schizo Affective Disorder
indication
Bipolar Disorder
indication
Major Depressive Disorder
indication
investigator
Nagy A Youssef, MD, PhD
person